Results 281 to 290 of about 166,859 (297)

Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis

New England Journal of Medicine, 2015
Bruce Strober, Alan Menter, Kenneth B Gordon   +2 more
exaly  

Psoriasis

SKINmed: Dermatology for the Clinician, 2002
openaire   +2 more sources

Interleukin-36–Receptor Antagonist Deficiency and Generalized Pustular Psoriasis

New England Journal of Medicine, 2011
Blair R Renshaw, Anne Puel, C Cluzeau
exaly  

Treatment of Psoriasis

New England Journal of Medicine, 1995
Malcolm W Greaves, Gerald D Weinstein, G D Weinstein   +2 more
exaly  

Anti-CD1a antibody reduces inflammation in psoriasis

Nature Reviews Drug Discovery, 2016
Megan Cully, Cully Megan
exaly  

Psoriasis

Journal of the American Academy of Dermatology, 1984
G G, Krueger, P R, Bergstresser, N J, Lowe, J J, Voorhees, G D, Weinstein   +4 more
openaire   +2 more sources

Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis

New England Journal of Medicine, 2019
Hervé Bachelez, Siew Eng Choon, A D Burden   +2 more
exaly  

Cyclosporine for Plaque-Type Psoriasis

New England Journal of Medicine, 1991
Charles N Ellis, Ted A Hamilton, Thomas M Annesley   +2 more
exaly  

Psoriasis

British Journal of Hospital Medicine, 2018
Stephen J, Mounsey, Elizabeth, Kulakov
openaire   +2 more sources

The psoriasis drugs market

Nature Reviews Drug Discovery, 2015
exaly